This is a working overview of Reverse-phase HPLC, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-02-17 and is reviewed periodically as new material appears.
The fragment most often associated with the name carries the sequence Ac-LKKTETQ, matching residues 17 through 23 of thymosin beta-4. That region holds the actin-binding motif responsible for much of the parent protein's biochemical activity. Apart from N-terminal acetylation the peptide is unmodified and contains no disulfide bonds, so it shows little ordered secondary structure in solution. Full-length thymosin beta-4 is instead a 43-residue polypeptide of roughly 4.9 kDa found widely across mammalian cell types.
Material sold under this label typically arrives as a freeze-dried powder in a sealed vial with a certificate of analysis. Such certificates usually report reversed-phase chromatography purity plus a mass confirmation, and stated purities commonly sit between 95 and 99 percent. Counter-ion identity, residual trifluoroacetate, water content, and peptide net weight are separate specifications that a certificate may or may not include. A purity figure alone does not establish sequence identity, so independent mass verification remains the practical check.
The designation TB-500 circulates in laboratory and catalog contexts without a single agreed definition. Most product listings apply it to an N-terminally acetylated seven-residue fragment of thymosin beta-4, while other listings attach the same label to the full 43-residue protein. Because the term is commercial rather than systematic, two entries bearing identical names may describe different molecules. Any documentation should therefore state which sequence a given sample is claimed to contain.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography together with mass spectrometry. The chromatogram provides a purity estimate as a percentage of total peak area, while the mass spectrum confirms that the observed mass matches the expected value. Amino acid analysis or tandem mass spectrometry sequencing can provide additional confirmation. Reported purity figures depend on the column, gradient, and detection wavelength, so values from different laboratories are not directly comparable without method details.
Lyophilised peptide is normally reconstituted with sterile water or a neutral buffer shortly before use. Because repeated freeze-thaw cycles can degrade the material, dividing a reconstituted solution into single-use aliquots is a common practice. Working solutions are usually kept cold and protected from light. The exact shelf life depends on concentration, buffer composition, and handling, so it is often determined empirically rather than assumed.
| Property | Value | Notes |
|---|---|---|
| Molecular mass | ≈889 Da for the 7-residue fragment | Full-length thymosin beta-4 is ≈4.9 kDa; catalogs differ |
| Appearance | White to off-white powder | Hygroscopic; weight shifts with residual moisture |
| Solubility class | Freely soluble in water | Also dissolves in aqueous buffers; poorly soluble in nonpolar solvents |
| Typical storage temperature | −20 °C, desiccated, protected from light | Once rehydrated, short-term holding at 2-8 °C |
| Typical analytical method | Reversed-phase HPLC with mass spectrometry | Purity by UV absorbance; identity by ESI-MS or MALDI-TOF |
Regulatory status differs by country, but TB-500 is not an approved pharmaceutical in major jurisdictions. It is commonly sold as a research chemical for laboratory use, which places responsibility for identity and purity on the supplier and the laboratory. Published human data are limited, and most reports involve preclinical models or cell culture. Questions about whether the fragment mimics all actions of thymosin beta-4, and under which conditions, remain open. Independent verification of any material is therefore a practical requirement in research settings.
TB-500 is a synthetic heptapeptide with the sequence Ac-LKKTETQ. It corresponds to a short N-terminal region of thymosin beta-4, a 43-amino-acid protein found in many cell types. The fragment contains an actin-binding motif, which is one reason it appears in laboratory studies of cell migration and cytoskeletal dynamics. TB-500 is not the full-length protein and is produced as a research chemical rather than an approved therapeutic agent. Its molecular weight is approximately 889 Da.
Purity and identity are separate measurements and are often confused. Reverse-phase high-performance liquid chromatography, usually with ultraviolet detection near 214 nanometres, reports the share of total peak area belonging to the target compound. Mass spectrometry by electrospray or matrix-assisted laser desorption then checks whether the observed mass matches the expected sequence. Neither measurement alone shows that a vial holds the intended peptide. Peptide content, meaning the fraction of vial mass that is genuine peptide rather than counter-ion, water or residual acid, is reported separately and is frequently lower than the stated purity figure.
The regulatory position is broadly consistent across major jurisdictions: no thymosin beta-4 fragment is an approved medicine, and laboratory material is commonly labelled as not intended for human consumption. Anti-doping rules in sport list thymosin beta-4 and its fragments among prohibited peptide hormones. Because these products travel through research-chemical channels rather than pharmaceutical supply chains, quality varies considerably between vendors. Independent testing of identity, purity and sterility is the only dependable check, and a certificate of analysis describes one batch rather than a supplier's whole catalogue.
Lyophilized peptide powder is normally held desiccated at −20 °C, with −80 °C used for longer storage periods. Allowing a sealed vial to reach room temperature before opening is standard practice, because condensation forming on cold powder introduces moisture. Once dissolved, solutions are typically kept cold and shielded from light. Repeated freeze-thaw cycles are avoided because they encourage aggregation and gradual loss of material. These conventions are general to synthetic peptides rather than unique to any one sequence.
No major regulatory agency has approved TB-500 for therapeutic use, and it holds no pharmacopoeial monograph. The name appears on the World Anti-Doping Agency prohibited list within the class covering peptide hormones, growth factors, and related substances. Detection in doping control relies on mass spectrometric methods applied to urine, often after preparation steps that concentrate the analyte. Discussion of TB-500 therefore clusters in biochemistry, sports medicine, and anti-doping literature rather than in registered clinical trials.
TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.
Thymosin beta-4 was isolated from calf thymus in the early 1980s and later characterised as an abundant intracellular actin-sequestering protein. Interest in short synthetic fragments grew once the actin-binding motif had been mapped to the middle of the sequence. TB-500 came out of that line of work as a truncated analogue rather than a natural isolate, and it is now sold mainly to laboratories. Published studies on the fragment have been largely in vitro or in animal models, and controlled human trials remain sparse, so claims about effects in people rest on extrapolation.
Literature and online discussion often conflate TB-500 with full-length thymosin beta-4, even though the two differ in size and are not interchangeable in analytical terms. The fragment is produced by solid-phase peptide synthesis, and the product is a defined seven-residue chain rather than a biological extract. Because the term is a trade-style label, two vendors may supply materials of the same nominal sequence but different counter-ion content, purity, or water content. Comparisons across studies are therefore difficult unless the exact sequence and purity are reported.
Convergent evolution—the repeated evolution of similar traits in multiple lineages which all ancestrally lack the trait—is rife in nature, as illustrated by the examples below. The ultimate cause of convergence is usually a similar evolutionary biome, as similar environments will select for similar traits in any species occupying the same ecological niche, even if those species are only distantly related. In the case of cryptic species, it can create species which are only distinguishable by analysing their genetics. Distantly related organisms often develop analogous structures by adapting to similar environments.
On November 25, Karriem was arraigned on charges of first-degree murder; he pleaded guilty, but his bizarre courtroom behavior convinced witnesses of his insanity. Judge John P. Scallen appointed three psychiatrists. Karriem was described as throwing furniture at other prisoners. Papers described Karriem's confinement in a padded cell of the County Jail, writing "The lustful flame of jungle fanaticism which tortured Harris into murdering Smith, seemed to have died away in him, temporarily at least, Saturday [November 26]." On November 28, "Negro leaders" in Detroit publicly voiced opposition to the "cult". By November 29, police had seized ATI literature including a registry of 8,000 members. On November 30, papers reported that Ugan Ali was likely insane, while Fard was reported as "not driven into his sinister teaching through insanity". On December 1, papers announce that the roster of ATI members had been conveyed to the Welfare Departments; Recipients were to be banned from welfare if they retained their membership. On December 6, the three psychiatrists testified that Karriem was legally insane, and he was committed to the Ionia State Hospital for the Criminal Insane. On December 6, Ugan Ali was released after promising to help disband the Allah Temple of Islam, while Fard agreed to forever leave Detroit as a condition of release. In the state hospital, Karriem was diagnosed with dementia praecox. He died there on June 19, 1935, of "mitral insufficiency and decompensation".
=== In vitro studies === Cell culture studies have reported that D-ribose-L-cysteine increases glutathione levels and modulates oxidative stress responses in normal cell lines exposed to cytotoxic agents.
=== Emerging fields === Photopharmacology is an emerging approach in medicine in which drugs are activated and deactivated with light. The energy of light is used to change for shape and chemical properties of the drug, resulting in different biological activity. This is done to ultimately achieve control when and where drugs are active in a reversible manner, to prevent side effects and pollution of drugs into the environment. Epigenetic therapy may offer an alternative 'master switch' to gene therapy to introduce persistent changes to the phenotype. Aging is well-known to be measurable through epigenetic clock. Drugs may induce persistent changes. When they cause drugs to lose efficacy, it is called drug tolerance. On the other hand, they may introduce benign changes to the body. Psychoplastogen produce profound effects by regulating neuroplasticity. Psychostimulants prevent grey matter loss in ADHD patients, at therapeutic doses.
In a study with 17 volunteers, blood and saliva samples were collected before and at 15, 30, 60 and 240 min after ingesting 1 g of paracetamol. Detection from stimulated saliva and plasma with PA-MS provided a reliable result that can aid in making timely treatment decisions. Moreover, participants' views of blood and saliva sampling procedures were assessed qualitatively, showing a preference for non-invasive sampling.
Sources: en.wikipedia.org
Osavampator (developmental code names TAK-653 and NBI-1065845) is an experimental drug being investigated as a treatment for treatment-resistant depression. It is being developed by Neurocrine Biosciences and Takeda Pharmaceuticals (Millennium Pharmaceuticals, Inc.). Takeda Pharmaceuticals discovered the molecule originally, and holds exclusive right to market the drug in Japan, while Neurocrine Biosciences holds the right to market it to the rest of the world.
A 2017 systematic review and meta-analysis of suvorexant for the treatment of insomnia found that the medication significantly increased the rate of somnolence by 3.5-fold, daytime sleepiness/sedation by 3.1-fold, fatigue by 2.1-fold, abnormal dreams by 2.1-fold, and dry mouth by 2.0-fold. Conversely, suvorexant did not significantly differ from placebo in the rates of any other assessed adverse effects. This included back pain, diarrhea, dizziness, falls, headache, car accidents/traffic violations, nasopharyngitis, nausea, potential drug misuse, suicidal ideation, complex sleep behaviors, hypnagogic or hypnopompic hallucinations, and sleep paralysis. The overall risk of any adverse event was increased 1.07-fold while discontinuation due to adverse events was unchanged (RRTooltip relative risk=0.93, 95% CITooltip confidence interval 0.60 to 1.44). Tolerance, dependence, withdrawal, and rebound effects do not appear to occur with suvorexant in the treatment of insomnia at studied doses. In three-month clinical studies, no rebound insomnia as assessed by measures of sleep onset or maintenance was observed with discontinuation of suvorexant at doses of 15 to 40 mg. Similarly, no withdrawal effects were observed with discontinuation of suvorexant at these doses. However, in other reports, some tolerance as assessed by diminishing somnolence and rebound insomnia upon discontinuation has been noted. The orexin neuropeptides augment the signaling of the mesolimbic dopamine reward pathway and are thought to potentiate hedonic tone.
== Advantages == DBS has important characteristics that make it suitable for current and future applications. It presents minimal potential risk of bacterial contamination and/or hemolysis. It is an easy, non-invasive and economical collection method. DBS samples can be stored for extended periods with almost no deterioration of the analytes, and they require less blood compared to conventional venipuncture. It is the ideal method for remote or at home sampling, especially useful in rural areas.
== Regulation == The regulation of the glyoxylate cycle involves carbon source availability, as it controls the transcriptional levels of key enzymes. Carbon catabolite repression is the main process that occurs in bacteria and fungi that regulates the transcriptional levels of the glyoxylate cycle, ensuring that the cycle is activated when glucose is not available. For instance, in Escherichia coli, the regulation of the isocitrate branch point takes place by regulating the transcription level of IclR and FadR, and through AceK, which is a bifunctional enzyme that acts as both a dehydrogenase kinase and a phosphatase. AceK is responsible for the regulation of isocitrate dehydrogenase and its switching roles in the citric acid cycle as well as the glyoxylate cycle. It determines whether the carbon atoms will be used in the glyoxylate cycle or the citric acid cycle. The phosphorylation, catalyzed by the AceK kinase function, of isocitrate dehydrogenase decreases its activity, and this phosphorylation can be reversed. In plants, the regulation of the glyoxylate cycle is achieved by regulating transcriptional levels during the seed germination process and through the mobilization of stored lipids . In bacteria, such as Mycobacterium tuberculosis, the glyoxylate cycle is up regulated especially when glucose is scarce and is needed during host infection. This regulation contributes to the growth and virulence of the pathogenic infection. Overall, these regulations allow for the conservation of carbon and activate the biosynthesis of key metabolites when carbon source is limited.
=== Lieutenant Governors (1919–1932) === Édouard Hesling (9 November 1919 – 7 August 1927) Robert Arnaud (7 August 1927 – 13 January 1928), acting Albéric Fournier (13 January 1928 – 22 December 1932) Gabriel Descemet (22 December 1932 – 31 December 1932)
Sources: en.wikipedia.org
== Redox activity == Most selenoproteins have a redox function analogous to proteins with Cys active sites. Two residues of Sec can be oxidized to form a diselenide bond (-Se-Se-), the selenium analog of the disulfide bridge. Sec can also form a selenenyl sulfide (-Se-S-) bond with Cys. The Se-H bond is more easily broken than the S-H bond, resulting in higher reactivity of the Sec residue compared to Cys. Also contributing to reactivity is the higher nucleophilicity, acidity, and leaving-group ability of selenolate (R-Se-) compared to thiolate (R-S-). The Se-Se bond is also weaker than the S-S bond. The result is that the Sec can easily be oxidized and reduced, without much change of getting stuck in one state. Sec is not more reactive than Cys in every single aspect. Selanyl radicals generated from Sec is less prone to attacking aromatic amino acid residues and protein Cα atoms than the thiyl radicals generated from Cys. This offers redox-active selenoproteins some protection from breaking itself apart compared to their cystine-only relatives.
==== Small RNA ==== At first, regulatory RNA was thought to be a eukaryotic phenomenon, a part of the explanation for why so much more transcription in higher organisms was seen than had been predicted. But as soon as researchers began to look for possible RNA regulators in bacteria, they turned up there as well, termed as small RNA (sRNA). Currently, the ubiquitous nature of systems of RNA regulation of genes has been discussed as support for the RNA World theory. There are indications that the enterobacterial sRNAs are involved in various cellular processes and seem to have significant role in stress responses such as membrane stress, starvation stress, phosphosugar stress and DNA damage. Also, it has been suggested that sRNAs have been evolved to have important role in stress responses because of their kinetic properties that allow for rapid response and stabilisation of the physiological state. Bacterial small RNAs generally act via antisense pairing with mRNA to down-regulate its translation, either by affecting stability or affecting cis-binding ability. Riboswitches have also been discovered. They are cis-acting regulatory RNA sequences acting allosterically. They change shape when they bind metabolites so that they gain or lose the ability to bind chromatin to regulate expression of genes.
This is a list of casual dining restaurant chains around the world, arranged in alphabetical order. A casual dining restaurant is a restaurant that serves moderately priced food in a casual atmosphere. Except for buffet-style restaurants and, more recently, fast casual restaurants, casual dining restaurants usually provide table service.
== Surveillance == Comparitech Limited, a UK technology advisor, published "The world's most-surveilled cities" in August 2019. It assembled data on the number of closed-circuit television (CCTV) cameras installed in 120 global cities. It then ranked the cities by number of cameras per 1,000 inhabitants. China's cities were found to be the most surveilled. Bangkok was ranked 31 (1=most surveilled; 120=least surveilled), with an estimated 53,429 cameras installed, or 5.16 cameras per 1,000 inhabitants. Other ASEAN cities were ranked: Singapore, 11 (86,000 cameras); Ho Chi Minh City, 72 (6,150 cameras); Yangon, 76 (2,995 cameras); Jakarta, 77 (6,000 cameras); Hanoi, 79 (4,400 cameras); Kuala Lumpur, 106, (1,000 cameras).
Sources: en.wikipedia.org
Usually not, though usage overlaps. The label most often refers to a short acetylated fragment of the parent protein, while thymosin beta-4 itself is the full 43-residue molecule. Because suppliers vary, a sequence statement is needed to settle the question for any particular lot.
The name is a commercial label rather than a systematic chemical designation, so different vendors and papers attach it to different sequences. Some treat it as a fragment and others as the whole protein. Comparing two reports therefore requires checking what each one actually analyzed.
Typically it reflects the relative area of the main peak in a reversed-phase chromatogram at a given wavelength. It does not confirm the amino acid sequence, the counter-ion, or the amount of peptide by mass. Identity is normally established by a separate mass measurement.
The lyophilised powder is typically held at -20 C or lower in a dry, dark place. Reconstituted solutions are aliquoted and frozen to avoid repeated freeze-thaw cycles.